Investigational drug access taken to task in lawsuit against FDA.
Randal
Judith
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D016265:Conflict of Interest; D017277:Drug Approval; D004345:Drug Industry; D011307:Drug Prescriptions; D015507:Drugs, Investigational / Q000627:therapeutic use*; D004645:Empathy; D000077156:Gefitinib; D006801:Humans; D007880:Legislation, Drug; D010344:Patient Advocacy; D011799:Quinazolines / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D011799:Quinazolines; D000068818:Cetuximab; D000077156:Gefitinib